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A B S T R A C T
Purpose: Optimized therapy in epilepsy should include individual care for cognitive functions. Here we
introduce a computerized screening instrument, called ‘‘Computerized Cognitive Testing in Epilepsy’’
(CCTE), which allows for time-efﬁcient repetitive assessment of the patient’s cognitive proﬁle regarding
the domains of memory and attention, which are frequently impaired due to side effects of antiepileptic
medication.
Methods: The CCTE battery takes 30 min and covers tasks of verbal and ﬁgural memory, cognitive speed,
attention and working memory. The patient’s results are displayed immediately in comparison to age-
related normative data. For evaluation of psychometrics and clinical correlations, data from patients of a
tertiary referral epilepsy center (n = 240) and healthy subjects (n = 83) were explored.
Results: CCTE subtests show good reliability and concurrent validity compared to standard
neuropsychological tests (p < 0.01). Adverse cognitive effects of antiepileptic medication can be
detected (p < 0.05), e.g. signiﬁcant negative effects of increasing drug load. Speciﬁc epilepsy subgroups,
e.g. focal versus primary generalized epilepsy or right versus left mesial temporal lobe epilepsy, showed
different CCTE proﬁles.
Conclusion: CCTE appears valuable for early detection of individual cognitive alterations related to
medication. In addition, it displays interesting differences between epilepsy syndromes. The CCTE
battery provides a standardized, time- and personnel-efﬁcient assessment of cognitive functions open to
a large number of patients and applicable for clinical and scientiﬁc use in epilepsy.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Cognitive functions and their maintenance play an important
role in chronic epilepsies. Various cognitive functions can be
inﬂuenced by seizures and epilepsy treatments, e.g. cognitive
speed, attention, short and long term memory.1–4 Cognitive
malfunction may be permanent, corresponding to lesion and/or
focus localization, for example poor verbal memory performance
in left mesial temporal lobe epilepsy (mTLE).5,6 On the other hand,
dynamic cognitive changes can relate to disease activity or side
effects of antiepileptic therapy.7–12 Antiepileptic drugs (AEDs)
often cause problems by dampening neuronal excitability and by
altering underlying systems, which can lead to impairment of* Corresponding author at: Epilepsy Center Erlangen (EZE), Schwabachanlage 6,
91054 Erlangen, Germany. Tel.: +49 9131 8544670.
E-mail address: katrin.kurzbuch@uk-erlangen.de (K. Kurzbuch).
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http://dx.doi.org/10.1016/j.seizure.2012.08.011cognitive functioning within various neuronal subsystems.13 AED
effects can be drug-speciﬁc and dose-dependent and may be
(supra-)additive in drug combinations.8 The latter is particularly
important as nearly 50% of epilepsy patients are on AED
polytherapy.14 Cognitive deterioration often seriously compro-
mises the patient’s ability to work and reduces quality of life and
compliance. Indeed, cognitive impairment – mainly regarding
memory and attention performance – is ranked among the most
important concerns by patients with epilepsy.15 Successful
treatment in epilepsy therefore should aim beyond seizure
freedom by focusing on an optimal balance between maximal
seizure control and minimal adverse effects. As cognitive perfor-
mance and side effects vary considerably among patients, the
individual cognitive assessment should focus on detecting
treatment impact on speciﬁc functions. Extensive assessment by
experienced neuropsychologists, as for example done within
presurgical evaluations,16 is hardly feasible in everyday practice
for large numbers of patients, especially in outpatient clinics and
private practices. This implies a risk of delaying or missing relevantvier Ltd. All rights reserved.
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tool meeting the requirements of daily clinical practice by
providing a standardized, valid and time-efﬁcient measurement
of cognitive functioning would be of great value.
Computer-supported neuropsychological testing has been
increasingly used in the diagnosis of neurological disorders
affecting cognition.18–22 Major beneﬁts of computerized methods
include automated data collection and efﬁciency of use.23 The
Computerized Cognitive Testing in Epilepsy (CCTE), as described
here, provides an effective and practical instrument for cognitive
proﬁle screening.24 CCTE evaluates established cognitive perfor-
mance in verbal and ﬁgural memory, cognitive speed, attention
and working memory in a patient-controlled manner and allows
for individual, age-related interpretation. In the current study, we
introduce the CCTE battery, discuss its methodological rationale
and present data from epilepsy and control subjects, supporting its
psychometric validity as well as its ability in characterizing
different and distinct cognitive proﬁles.
2. Methods
2.1. The CCTE battery
A Microsoft Windows operating system, 1024  768 resolution
and a sound card are required to run CCTE. Participants perform a
single session, seated with headphones in front of a touch screen
monitor connected to a notebook in a quiet surrounding. CCTE
delivers task instructions and materials verbally via headphones,
alongside with the same information in writing via visual display.
In a short training phase, each participant receives the opportunity
to practice using the touch screen, and volume of the headphones
can be adjusted individually.
CCTE consists of six tasks taking approximately 30 min to
complete in total. These subtests refer to the following established
neuropsychological paradigms. Task descriptions and screenshots
can be found in Table 1 and Fig. 1a–h.Table 1
CCTE subtests and measurements.
CCTE subtest Task description 
Working memory An increasing number of digits (spanning from 3 t
the participant. Immediately after the presentatio
ordered series by touching digits displayed on th
series. The task is ﬁnished when the participant fa
digits. First part: digits forward; second part: dig
Focused attention Out of 80 simple arithmetic expressions, the partic
respective label all 45 expressions that result in eve
quickly as possible and is ﬁnished as soon as all e
Visuospatial memory Given 13 everyday pictures of objects paired with
boxes on a screen, the participant is ﬁrst asked to to
by one. Next, the participant is asked to recall an
object in an array of blank boxes
Complex attention
and incidental memory
(a) As quickly as possible, the participant is asked t
is presented in the center of the screen. After the
another picture appears in the center of screen u
(b) In the second part of this task, the respondent is
recognize all objects previously seen from an arra
Verbal learning The task consists of AB–AC paired-associate learn
moderately related) are presented in three consec
trials are administered for word pairs with the sa
response words (e.g. AB: mother–child, AC: moth
both acoustically and in written form on the scre
presented the cue word and is asked to write the r
on the touch screen
Figural short term memory The respondent is given a series of 12 ﬁgures consi
each ﬁgure, six of the 36 squares are colored. Imm
each single ﬁgure, four ﬁgures are presented and t
previously seen ﬁgure1. The tasks digit span forward and backwards constitute the
neuropsychological standard paradigm to assess working
memory as the capacity to hold information in the mind and
to make it available for further information processing.25
2. In the focused attention task, a paradigm to assess speed of
information processing is employed using sequences of simple
calculations. Speed of information processing refers to how
quickly one can react to incoming information, understand it,
formulate and execute a response. This task also involves
attention, working memory and decision making.26 Perfor-
mance is affected e.g. by the neurotransmitter balance of the
brain, by the organization of neural networks supporting the
respective procedure, and by the efﬁciency of the frontal lobes in
organizing and directing information ﬂow. Brain lesions, toxic
substances and a variety of medications, including anti-
convulsants, can slow information processing which often
accompanies cognitive decline.17,27
3. The visuospatial memory subtest examines the ability of storing
and reconstructing the initial spatial arrangement of visually
presented information, which is necessary for remembering the
location of objects as well as orientation and navigation within
one’s environment.28 Visual memory deﬁcits are predominantly
associated with lesions in the non-dominant mesial temporal
lobe.29
4a. The complex attention task refers to the paradigm of visual
scanning as the ability to actively explore the visual
surrounding and to ﬁnd relevant visual information in a fast
and efﬁcient way, e.g. a particular object among other objects.
This requires gaze control, ﬁxation, controlling one’s focus of
visual attention and the ability to plan behavior systematically.
Visual scanning deﬁcits may result from a variety of brain
diseases, neurotoxic substances and medications.30
4b. In the task of incidental memory, the paradigm of uninten-
tional learning is represented, which means the random
reception of information occurring in one’s environment. As
this experimental paradigm contains the unexpected demandMeasurement
o 9 digits) is presented acoustically to
n, he or she is asked to repeat the
e screen. There are two trials for each
ils two times on the same number of
its reversed
Maximal length of correctly
reproduced digit sequences
ipant is asked to ﬁnd and touch on the
n sums. The task is to be completed as
ven results are found
Time needed to complete the task
 13 spatial locations represented by
uch the objects as they are named one
d identify the spatial location of each
Number of correctly recognized
picture locations
o ﬁnd and touch the same picture that
 correct picture has been touched,
ntil all 24 pictures are presented
 asked, without previous instruction, to
y of 48 written words
(a) Average speed of response
(b) Number of correctly
memorized objects
ing. Eight word pairs (four of them
utive learning trials. Three additional
me cue words but with different
er–father). The presentation is given
en. After each trial, the respondent is
esponse word with a virtual keyboard
Number of correctly
reproduced words
sting of 6-by-6 squares of equal size. In
ediately after the 5-s presentation of
he respondent is asked to indicate the
Number of correctly
recognized ﬁgures
Fig. 1. (a) CCTE test setting. (b) Digit span task. (c) Focused attention task. (d) Visuospatial memory task. (e) Complex attention task. (f) Incidental memory task. (g) Verbal
memory task. (h) Figural memory task.
K. Kurzbuch et al. / Seizure 22 (2013) 424–432426of recalling previously seen objects, it differs from intentional
learning and refers to daily life memory demands.31
5. The verbal learning task refers to the learning of semantically
associated and unassociated word pairs, a traditional neuro-
psychological standard paradigm to assess verbal memory,
introduced by Hermann Ebbinghaus (1850–1909) and used in a
variety of neuropsychological memory test batteries (i.e.
Wechsler Memory Scale). Here, a paired-associate presentation
and retrieval of stimulus and response are given.32 Verbal
memory deﬁcits characteristically accompany lesions in the
mesial temporal lobe structures of the dominant hemisphere.33
6. The ﬁgural short term memory task represents a paradigm to
assess working memory for ﬁgural material, as the capacity to
store non-verbal information and to recognize it out of similar
stimuli, a paradigm used in different neuropsychological test
batteries.34The course of subtests is controlled by a script directing the
participant through the tasks without any external assistance. After
some short instructions, each task is started by the patient himself.
Immediately after completion, age-related results are displayed in
raw values and z-scores and presented in graphic form. For follow-
up examinations, the battery is available in two parallel versions,
referred to as versions ‘‘A’’ and ‘‘B’’, comprising the same task
structure but differing slightly in the presented words and pictures.
2.1.1. Results display – example (Fig. 2)
Original raw scores and z-values for each subtest are separately
listed in comparison to respective age-related norm values. Patient
scores are displayed graphically: the bold circle represents norm
mean value level (z = 0), inner and outer rings illustrate up to 3
standard deviations (z = +3/3); black lines connecting individual
subtest values illustrate the patient’s performance.
Fig. 2. Cognitive proﬁle as evaluated by CCTE: test results indicate normal cognitive functions in this 50-year-old female patient with newly diagnosed epilepsy before
initiating AED treatment.
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The patient group comprised unselected male and female
patients with active epilepsy from the Epilepsy Center Erlangen
(n = 240). To ensure comparability of examined groups, patients
with an IQ below 85 (based on the Mehrfachwahl-Wortschatz-
Intelligenz test (MWT-B), a German assessment of verbal intelli-
gence) were excluded from the study. All participants gave
informed consent prior to their inclusion in the study; approval
was given by the local ethics committee. For control data, healthy
male and female volunteers were evaluated (n = 83). Exclusion
criteria for healthy controls included history of any psychiatric or
neurological disorders and IQ below 85.
2.3. Psychometric evaluation
For psychometric evaluation of CCTE, retest reliability and
construct validation with standard neuropsychological means as
well as a factor analysis were conducted.
2.3.1. Retest reliability
To survey test–retest reliability of CCTE, a group of 46 patients
completed the test twice at an interval of three months remaining
on stable medication between both investigations. Daytime,
location and caring professional were the same in both sessions.
Participants were randomized; half of them took version A at the
ﬁrst test and parallel version B at the second test, the other half vice
versa.
2.3.2. Construct validation
To determine whether the CCTE subtests give similar results as
comparable established methods measuring the same theoretical
construct, epilepsy patients undergoing comprehensive assess-
ment with established test instruments also performed CCTE
within the next ﬁve days. In detail, representative patient groups
completed the Trail Making Test (TMT-A, a measure for cognitive
processing speed)35 as well as German versions of the Diagnos-
ticum for Cerebral Impairment (DCS – a measure of ﬁgural
memory),36 the Rey Auditory Verbal Learning Test (VLMT – a
measure of verbal learning and memory)37 and parts of theWechsler Memory Scale-Revised (WMS-R – a measure of verbal
learning).34 Test scores were compared to the representative CCTE
subtests using Pearson’s product-moment correlation. To work out
how much an individual’s score must differ from test 1 to test 2 to
mark a statistically signiﬁcant change, reliable change indices (RCI)
were calculated for each subtest.
2.3.3. Factor analysis
Principal component factor analysis was applied to uncover
comprehensive cognitive parameters underlying the pattern of
correlations between the different subtests of CCTE. We used CCTE
subtest raw scores from the total sample of subjects. Extraction
criterion was an Eigenvalue > 1, as factor rotation (Varimax) with
Kaiser normalization was used.
2.4. Clinical correlations
CCTE patient results were compared against healthy controls
and across different patients groups and clinical parameters, e.g.
number of AED or epilepsy syndrome (focal versus generalized
epilepsies; left versus right mesial temporal lobe epilepsy; patients
without AED (before treatment) versus AED monotherapy versus
AED polytherapy). Scores were compared using independent
t-tests.
Statistical analysis was performed with SPSS 18 for Windows
(PASW Statistics 18.0, SPSS Inc., 2009). Two-tailed statistics were
used throughout deﬁning signiﬁcance by p < 0.05.
3. Results
3.1. Patient population
Table 2 summarizes patient and control characteristics.
3.2. Psychometric evaluation
The control group, spanning four decades, was divided in three
age groups: 20–30, 31–50 and 51–60 years, addressing possible
age-related impact on the examined cognitive functions. Table 3
shows results of the CCTE subtests for the age groups.
Table 2
Demographic data and epilepsy characteristics.
Characteristics Patient group
(n = 240)
Control group
(n = 83)
Age (years)
Mean  SD 36.0  13.2
(19–62)
38.3  12.9
(20–60)
Sex (%)
Male 45.4 45.8
Female 54.6 54.2
Education level (%)
No special qualiﬁcation 22.7 9.7
Medium education 66.0 69.9
Higher education 11.3 20.4
Age of seizure onset (years) 19.9  13.8 (1–62)
Epilepsy syndrome (n)
Focal
TLE right (mTLE right) 48 (38)
TLE left (mTLE left) 41 (31)
Extratemporal 61
Other 72
Generalized 18
AED medication (n)
No AEDa 42
Monotherapy 79
Polytherapy 119
2 AED 88
3 AED 31
a Testing before initiating AED treatment.
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values 0.40  r  0.79). The ﬁgural memory subtest showed
improvement from test A to test B and no signiﬁcant test–retest
correlation (r = 0.08; p > 0.05). Table 4 shows reliability scores and
reliable change indices for signiﬁcant changes in individual
performance from test 1 to test 2.
Validity estimates according to Pearson for standard neuropsy-
chological means and respective CCTE subtests showed signiﬁcant
correlations (0.64  r  0.82; p < 0.01). Table 5 shows the com-
pared parameters and the respective correlations.Table 3
CCTE subtest mean scores (M) and standard deviations (SD) in the three age groups of
CCTE subtest 20–30 years (n = 31) 
M SD 
Digit span forward 6.10 1.08 
Digit span reversed 4.87 1.23 
Focused attention 106.52 56.97 
Visuospatial memory 10.10 2.27 
Complex attention 1.49 0.21 
Incidental memory 15.58 4.77 
Verbal learning 39.97 6.34 
Figural memory 10.42 1.23 
Table 4
Retest-reliability, mean scores (M), standard deviations (SD), reliable change indices (R
CCTE subtest (n = 46) r M1 
Digit span forward 0.43** 5.98 
Digit span reversed 0.70** 4.35 
Focused attention 0.40** 104.57 
Visuospatial memory 0.53** 9.37 
Complex attention 0.79** 1.86 
Incidental memory 0.41** 15.06 
Verbal learning 0.79** 33.74 
Figural memory 0.08 9.93 
r, Pearson’s product-moment test–retest correlation.
** p < 0.01.
RCI, reliable change index (point score or reaction time difference which marks a signPrincipal component analysis (Eigenvalue > 1, Varimax rota-
tion) of raw scores from the total sample of subjects (n = 323)
extracted two factors. The ﬁrst factor, referred to as ‘‘ATTENTION’’,
comprises the subtests of digit span, focused attention, complex
attention and ﬁgural short term memory. The second factor,
referred to as ‘‘MEMORY’’, is covered by the subtests of visuospatial
memory, incidental memory and verbal memory. Factor loadings
are listed in Table 6. The model explained 58.8% of the variance.
3.3. Clinical correlations
CCTE subtest results appeared generally lower in epileptic
patients versus controls and differed between focal (n = 222) and
generalized epilepsies (n = 18) with lower values in partial
epilepsy in most subtests (p > 0.05) (Fig. 3a and Table 7a).
Left mTLE patients (n = 31) revealed worse CCTE results in the
verbal memory task (p < 0.05), as compared to right mTLE patients
(n = 38) (Fig. 3b and Table 7b).
Patients untreated (n = 42) showed better performance than
patients on AED monotherapy (n = 79) or AED polytherapy
(n = 119) (Fig. 3c and Table 7c). The two latter groups differed
signiﬁcantly (p < 0.05) with lower scores for patients on poly-
therapy than on monotherapy in most subtests. Comparisons
between untreated patients and patients on monotherapy did not
differ signiﬁcantly.
Patients on AED monotherapy (n = 79) did signiﬁcantly better
compared to patients on three or more AEDs (n = 31) in most
subtests (Fig. 3d and Table 7d).
Table 8 lists the frequencies of subaverage scores (z  1,0) for
each subtest in the groups of generalized/focal epilepsies, left/right
mesial temporal lobe epilepsies and patients on monotherapy/
polytherapy.
3.3.1. Individual patient example during treatment
Signiﬁcant changes of an individual cognitive proﬁle during
treatment adjustments are illustrated in Fig. 4. During her ﬁrst
assessment, the patient suffering from drug resistant focal epilepsy healthy controls.
31–50 years (n = 33) 51–60 years (n = 19)
M SD M SD
6.06 1.20 6.32 1.42
4.94 1.20 4.68 1.06
102.88 42.08 130.47 60.09
9.64 2.47 8.42 2.34
1.64 0.29 2.12 0.51
14.76 5.07 14.16 3.78
37.76 9.56 29.26 10.02
10.18 1.69 9.47 1.47
CI).
SD M2 SD RCI
1.18 5.87 1.31 2.47
1.37 4.76 1.16 2.08
36.06 97.85 60.03 77.42
2.62 9.85 2.82 4.98
0.54 1.82 0.48 0.69
4.16 13.17 4.03 8.86
11.55 37.59 11.33 11.43
1.25 10.33 1.41 3.32
iﬁcant change from test 1 to test 2); 95%-conﬁdence interval.
Table 6
Factor loadings of CCTE subtest scores.
CCTE subtest Factor
ATTENTION MEMORY
Digit span forward 0.74
Digit span reversed 0.74
Focused attention 0.71
Complex attention 0.63
Figural short term memory 0.77
Visuospatial memory 0.81
Incidental memory 0.75
Verbal memory 0.63
(n = 323).
Principal component analysis with Varimax rotation.
Table 5
CCTE subtests, established neuropsychological measures and their correlation
coefﬁcients (r).
CCTE subtest Established neuropsychological measure r
Digit span forward WMS-R: digit span forward 0.70**
Digit span reversed WMS-R: digit span backward 0.64**
Focused attention TMT-A: time of completion 0.68**
Visuospatial memory DCS: total learning score 0.77**
Complex attention TMT-A: time of completion 0.71**
Verbal learning VLMT: total learning score 0.81**
VLMT: delayed recall 0.67**
WMS-R: total learning score 0.82**
Figural memory DCS: total learning score 0.76**
DCS, Diagnostikumfu¨rcerebraleScha¨digung (a visual learning and memory test);
VLMT, German version of Rey Auditory Verbal Learning Test; WMS-R, word pair
task from Wechsler Memory Scale-R; TMT-A, Trail Making Test A.
r, Pearson’s product-moment correlation coefﬁcient.
** p < 0.01.
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severe cognitive impairment conﬁrmed by underperformance in
most subtests of the CCTE. After replacement of topiramate by
lamotrigine (150 mg/daily), three months later performance
improved in all previously impaired domains of CCTE.
4. Discussion
This study presents cognitive proﬁle data from epilepsy
patients, assessed by CCTE, a new computerized screening
instrument developed to facilitate the assessment of certain
cognitive functions in epileptic patients. CCTE tasks represent
computer adaptations of established neuropsychological para-
digms covering cognitive functions of working memory, verbal and
visuospatial/ﬁgural memory, cognitive speed and attention.
It could be demonstrated that CCTE provides correlations to
clinical syndromes and is able to show different degrees of
impaired cognition. It evidently captures the spectrum ofFig. 3. (a) CCTE subtest z-scores of healthy controls, patients suffering from focal epilepsie
and healthy controls. *Signiﬁcance p < 0.05. (c) CCTE subtest z-scores of untreated patien
for comparison of monotherapy/polytherapy. (d) CCTE subtest z-scores of patients on A
p < 0.05. DF, digit span forward; DR, digit span reversed; FA, focused attention; VM, v
memory; FM, ﬁgural memory.dysfunction in the measured cognitive domains in epilepsy
patients compared to healthy subjects. Differences between focal
and primary generalized epilepsies were shown, with a lower
performance of focal epilepsy patients (Fig. 3a). These differences
were non-signiﬁcant, nevertheless they seem to reﬂect the fact
that patients with localization-related epilepsy are often more
cognitively impaired due to the impact of the underlying brain
lesion.38,39
Patients with left mTLE differed from patients with right mTLE
by their signiﬁcantly lower performance in the verbal memory
subtest of CCTE, conﬁrming previous work.5,6 As words can be
typed on the touch screen, the verbal learning task of CCTE is
particularly sensitive to memory decline by demanding free recall
performance from the participant; while many other computer-
based memory tests rely on verbal memory recognition rather than
free recall, which is due to the lack of a suitable answering device.
Despite the lack of a delayed recall condition, the subtest provides
the experimental paradigm of pair-associate learning which serves
to be a good measure of unilateral lesions and hippocampal
learning40 and shows sufﬁcient correlation to delayed recall tasks.s and primary generalized epilepsies. (b) CCTE subtest z-scores of left and right mTLE
ts, AED monotherapy, AED polytherapy and healthy controls. *Signiﬁcance p < 0.05
ED monotherapy, therapy with 3 or more AEDs and healthy controls. *Signiﬁcance
isuospatial memory; CA, complex attention; IM, incidental memory; VEM, verbal
Table 7c
CCTE subtest mean scores (M) for the groups of patients with no AED/monotherapy/polytherapy and signiﬁcance of comparison (p).
CCTE subtest Untreated (n = 42) Monotherapy (n = 79) Polytherapy (n = 119) Untreated s. mono Mono versus poly
M SD M SD M SD p p
Digit span forward 5.60 1.13 5.67 1.22 5.21 1.10 0.739 0.007
Digit span reversed 4.38 1.01 4.33 1.21 3.87 1.22 0.813 0.009
Focused attention 125.45 52.76 124.35 63.01 144.98 74.01 0.923 0.053
Visuospatial memory 9.41 2.64 8.56 3.05 8.47 2.82 0.131 0.839
Complex attention 1.84 0.55 2.02 0.83 2.54 1.60 0.218 0.008
Incidental memory 14.67 4.48 13.69 4.48 13.22 5.07 0.259 0.508
Verbal memory 32.57 8.11 30.96 11.01 26.43 11.77 0.406 0.007
Figural memory 10.17 1.15 9.92 1.61 9.08 1.90 0.389 0.001
Table 7d
CCTE subtest mean scores (M) for the groups of patients on 1 AED versus 3 AED and signiﬁcance of comparison (p).
CCTE subtest 1 AED (n = 79) 3 AED (n = 31) p (t-test)
M SD M SD
Digit span forward 5.67 1.22 5.06 1.24 0.021
Digit span reversed 4.33 1.21 3.55 1.15 0.003
Focused attention 124.35 63.01 168.19 92.78 0.061
Visuospatial memory 8.56 3.05 7.61 2.75 0.137
Complex attention 2.02 0.83 2.85 1.53 0.000
Incidental memory 13.69 4.48 11.42 5.75 0.029
Verbal memory 30.96 11.01 22.06 12.48 0.000
Figural memory 9.92 1.61 8.32 2.14 0.000
Table 7a
CCTE subtest mean scores (M) for the groups of focal versus generalized epilepsies and signiﬁcance of comparison (p).
CCTE subtest Focal epilepsy (n = 222) Generalized epilepsy (n = 18) p (t-test)
M SD M SD
Digit span forward 5.41 1.23 5.56 0.70 0.611
Digit span reversed 4.07 1.25 4.17 0.99 0.749
Focused attention 131.96 66.31 138.83 70.56 0.675
Visuospatial memory 8.55 2.87 9.50 2.31 0.174
Complex attention 2.27 1.19 1.79 0.39 0.093
Incidental memory 13.47 4.71 14.61 5.94 0.338
Verbal memory 28.39 11.52 36.22 6.97 0.061
Figural memory 9.48 1.83 9.94 1.30 0.295
Table 7b
CCTE subtest mean scores (M) for the groups of left versus right mTLE and signiﬁcance of comparison (p).
CCTE subtest Left mTLE (n = 31) Right mTLE (n = 38) p (t-test)
M SD M SD
Digit span forward 5.32 1.43 5.50 1.20 0.576
Digit span reversed 4.23 1.26 4.13 1.04 0.735
Focused attention 116.26 53.38 135.95 67.78 0.192
Visuospatial memory 7.81 3.20 7.61 2.70 0.778
Complex attention 2.24 0.98 2.67 1.84 0.248
Incidental memory 13.00 4.85 13.55 3.29 0.576
Verbal memory 24.19 12.35 35.37 10.86 0.025
Figural memory 9.52 1.20 9.05 2.03 0.345
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monitoring possible cognitive adverse effects of AED, often
exacerbated by polytherapy.41,42 Impairing effects of medication
are demonstrated by CCTE performance proﬁles (Fig. 3c and d),
showing a signiﬁcantly negative impact of administration of three
or more AEDs. This underlines the importance of identifying and
minimizing deteriorations in the individual cognitive proﬁle over
the course of therapy in order to preserve school and job
performance. Topiramate’s potential negative effects on language,memory and cognitive speed are well described in previous
studies43,44 and are reﬂected in the improvement of the presented
patient’s CCTE proﬁle after withdrawal (Fig. 4).
Psychometric evaluation was conducted to estimate reliability
and validity of the test battery. Test–retest calculations showed
good correlations, providing evidence for sufﬁcient reliability.
Construct validity was estimated by correlating CCTE subtests with
established neuropsychological measures. The results indicated
that the test battery is a valid and sensitive assessment tool to
Table 8
Frequencies of subaverage performance (z  1,0) in the groups in %.
CCTE subtest General epilepsy Focal epilepsy Left mTLE Right mTLE Monotherapy Polytherapy
Digit span forward 44 37 32 32 30 42
Digit span reversed 22 31 32 24 24 37
Focused attention 22 19 6 26 20 27
Visuospatial memory 33 36 38 47 34 38
Complex attention 39 39 52 47 42 60
Incidental memory 28 20 26 8 15 25
Verbal memory 28 50 65 39 46 55
Figural memory 39 27 26 34 20 39
Fig. 4. CCTE proﬁles of a 21 years old female patient with cryptogenic epilepsy. Assessment 1 under medication with topiramate (gray lines), assessment 2 after replacement
of topiramate (black lines). A clear improvement was seen in the majority of subtests.
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including working, verbal and ﬁgural memory as well as attention.
By conducting factor analysis, two major components could be
extracted, representing the neuropsychological domains of atten-
tion and memory. Both domains are especially vulnerable for
negative drug effects and are often cause for complaint by patients.
Although computerized assessment has certain important
advantages, a relatively short screening cannot provide the
amount of data generated by a full neuropsychological examina-
tion, as it is required in pre-surgical evaluation.45,46 Therefore, a
screening system like CCTE does not make a claim to measure the
entire spectrum of cognitive domains. It rather aims to capture
those functions which are most likely to be impaired by
antiepileptic medication and have crucial effect on the patient’s
everyday performance – which particularly applies to memory and
attention. CCTE enables administration of cognitive screening for
certain frequent deﬁcits for many patients in an economic fashion,
especially in an outpatient setting. Early detection of deﬁcits
facilitates an in time intervention.
Certain advantages arise from the computer-based structure of
CCTE.23,47 Without external assistance, the test battery can be
accomplished by the examinee in about 30 min. Administration
and stimulus presentation are provided in a standardized,
multimodal and objective way, independent from an examiner
and thus excluding tester bias and variation in the delivery of
instructions. Automated comparison with age-related norms is
provided as graphical proﬁle immediately after the test. The data of
different examinations of the same examinee can be shown in one
proﬁle, which enables a comparison in follow-up assessment. Theindividual results in graphical form can be easily interpreted and
explained to the patient. More detailed single case analysis is
enabled and provides precise reaction times, response latencies
and correctness of response as well as learning curves and
interferences or lateral preferences.
Another advantage lies in the high participant acceptance of
computerized assessments.48 As the test challenge seems playful,
no excessive pressure is put on the examinee, mitigating anxiety
and stress. Because of the short duration, a steady motivation is
facilitated and fatigue effects are prevented. Nevertheless, limita-
tions of computerized assessments may become evident when
possible reduced ﬁne motor skills or lack of computer practice of an
individual patient interferes with efﬁciently interacting with the
computerized device.47 However, because the examinee uses an
arbitrary ﬁnger to communicate with the touch screen of CCTE and
there is no need for other devices such as a keyboard or computer
mouse, handling is kept easy for most patients. Nevertheless, some
problems were experienced with a minority of cognitively more
severely impaired patients who had problems to understand
instructions instantly and needed further explanations.
There are two parallel CCTE versions at present, additional
parallel forms are currently developed. In this study, tests were
administered in German language. Since all of the CCTE text parts
are deposited in external text ﬁles coded in Unicode, the program
can be translated into any other language. Multilingual versions
are in progress and could open the way for valuable transcultural
comparisons. Because of the script structure, the number of tasks is
expandable. As electronic ﬁling is integrated in the program and
data can be exported in other ﬁle structures, the aspect of data
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the battery is suitable for implementation of neuropsychological
assessment into scientiﬁc studies in a standardized and compre-
hensive way, involving large patient samples. This makes it an
interesting tool for e.g. multi-center treatment outcome studies or
telemedicine settings, respectively.
5. Conclusion
The present study demonstrates that the computer-based test
CCTE can provide effective screening for memory and attention
functions in epilepsy. CCTE covers different aspects of these
cognitive domains and is able to show different levels of cognitive
impairment, especially related to antiepileptic medication. Due to
program structure, computerized setting and short duration, the
system proved to be time- and personnel-efﬁcient and of high
feasibility, usability and acceptance by patients. These factors
make CCTE potentially suitable for outpatient units to screen
individual cognitive proﬁles and to monitor unwanted AED related
cognitive side effects or changes over the course of therapy. By
virtue of its computerized structure, CCTE may also be applicable
in scientiﬁc multi-center studies and telemedicine.
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